• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.桥粒 COP9 调控致心律失常性右室心肌病/发育不良中的蛋白质组降解。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI137689.
2
Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers.根据修订后的 2010 年工作组标准,包括非桥粒磷酸酶兔肌球蛋白结合蛋白 C 突变携带者的致心律失常性右室发育不良/心肌病。
Am J Cardiol. 2013 Oct 15;112(8):1197-206. doi: 10.1016/j.amjcard.2013.06.017. Epub 2013 Jul 19.
3
CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.CSN6 通过抑制 SIRT2 加剧 Ang II 诱导的心肌细胞肥大。
Exp Cell Res. 2020 Nov 1;396(1):112245. doi: 10.1016/j.yexcr.2020.112245. Epub 2020 Aug 31.
4
Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations.在没有桥粒突变的患者中,运动在致心律失常性右心室发育不良/心肌病的发病机制中起着不成比例的作用。
J Am Heart Assoc. 2014 Dec;3(6):e001471. doi: 10.1161/JAHA.114.001471.
5
Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease.致心律失常性右室心肌病:对疾病机制的新认识。
Cardiovasc Pathol. 2010 May-Jun;19(3):166-70. doi: 10.1016/j.carpath.2009.10.006. Epub 2010 Jan 6.
6
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.运动增加致心律失常性右室心肌病/心律失常性右室发育不良相关桥粒突变携带者与年龄相关的外显率和心律失常风险。
J Am Coll Cardiol. 2013 Oct 1;62(14):1290-1297. doi: 10.1016/j.jacc.2013.06.033. Epub 2013 Jul 17.
7
Electrocardiographic differences in desmosomal and non-desmosomal arrhythmogenic cardiomyopathy.桥粒性与非桥粒性致心律失常性心肌病的心电图差异
Int J Cardiol. 2016 Jan 15;203:1005-6. doi: 10.1016/j.ijcard.2015.11.089. Epub 2015 Nov 17.
8
Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2.与桥粒基因桥粒芯胶蛋白-2突变相关的致心律失常性右室发育不良/心肌病
Am J Hum Genet. 2006 Nov;79(5):978-84. doi: 10.1086/509122. Epub 2006 Sep 27.
9
Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.心脏磁共振成像在致心律失常性右室心肌病/心律失常性右室发育不良相关桥粒突变携带者心律失常风险分层中的增量价值。
J Am Coll Cardiol. 2013 Nov 5;62(19):1761-9. doi: 10.1016/j.jacc.2012.11.087. Epub 2013 Jun 27.
10
Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations.致心律失常性右心室发育不良/心肌病及桥粒基因突变患者的运动
Herz. 2015 May;40(3):402-9. doi: 10.1007/s00059-015-4223-5.

引用本文的文献

1
Machine learning analysis of ARVC informed by sodium channel protein-based interactome networks.基于钠通道蛋白相互作用组网络的致心律失常性右室心肌病机器学习分析
Front Pharmacol. 2025 Jul 23;16:1611342. doi: 10.3389/fphar.2025.1611342. eCollection 2025.
2
Cardiac Myocyte Cytosolic Self-DNA Contributes to the Pathogenesis of Desmoplakin-Cardiomyopathy.心肌细胞胞质中的自身DNA促成桥粒斑蛋白心肌病的发病机制。
JCI Insight. 2025 Jul 3. doi: 10.1172/jci.insight.192283.
3
Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics.桥粒斑蛋白 2 基因治疗可预防和挽救携带患者遗传基因的小鼠模型中的心律失常性右室心肌病。
Nat Cardiovasc Res. 2023 Dec;2(12):1246-1261. doi: 10.1038/s44161-023-00370-3. Epub 2023 Dec 7.
4
Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy.腺相关病毒介导的桥粒斑蛋白2恢复在致心律失常性心肌病中的治疗效果
Nat Cardiovasc Res. 2023;2(12):1262-1276. doi: 10.1038/s44161-023-00378-9. Epub 2023 Dec 7.
5
Emerging Roles of Cullin-RING Ubiquitin Ligases in Cardiac Development.Cullin-RING 泛素连接酶在心脏发育中的新兴作用。
Cells. 2024 Jan 26;13(3):235. doi: 10.3390/cells13030235.
6
Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology.致心律失常性右室心肌病:从临床前模型到基因型-表型相关性及病理生理学。
Stem Cell Rev Rep. 2023 Nov;19(8):2683-2708. doi: 10.1007/s12015-023-10615-0. Epub 2023 Sep 20.
7
Genetic inactivation of β-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.β-catenin 的遗传失活是有益的,而其激活在桥粒芯糖蛋白心肌病中是有害的。
Cardiovasc Res. 2023 Dec 30;119(17):2712-2728. doi: 10.1093/cvr/cvad137.
8
Cardiomyocyte external mechanical unloading activates modifications of α-actinin differently from sarcomere-originated unloading.心肌细胞外部机械卸载激活α-辅肌动蛋白的修饰不同于来源于肌节的卸载。
FEBS J. 2023 Nov;290(22):5322-5339. doi: 10.1111/febs.16925. Epub 2023 Aug 17.
9
Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension.Cullin 3 与血压调节:家族性高血钾性高血压的启示。
Hypertension. 2023 May;80(5):912-923. doi: 10.1161/HYPERTENSIONAHA.123.20525. Epub 2023 Mar 2.
10
PANoptosis is a prominent feature of desmoplakin cardiomyopathy.全细胞程序性坏死是桥粒斑蛋白心肌病的一个显著特征。
J Cardiovasc Aging. 2023 Feb;3(1). doi: 10.20517/jca.2022.34. Epub 2023 Jan 1.

本文引用的文献

1
Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases.COP9 信号体(CSN)在心血管疾病中的作用。
Biomolecules. 2019 Jun 5;9(6):217. doi: 10.3390/biom9060217.
2
Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病的遗传学及发病机制
Biophys Rev. 2018 Aug;10(4):973-982. doi: 10.1007/s12551-018-0437-0. Epub 2018 Jul 11.
3
Desmosomes in Human Disease.黏着斑在人类疾病中的作用。
Annu Rev Pathol. 2018 Jan 24;13:51-70. doi: 10.1146/annurev-pathol-020117-044030.
4
Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.致心律失常性右室心肌病患者异丙肾上腺素试验与运动试验的心律失常反应。
Europace. 2018 Jun 1;20(FI1):f30-f36. doi: 10.1093/europace/euy007.
5
YASARA: A Tool to Obtain Structural Guidance in Biocatalytic Investigations.YASARA:一种在生物催化研究中获取结构指导的工具。
Methods Mol Biol. 2018;1685:43-67. doi: 10.1007/978-1-4939-7366-8_4.
6
CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method.CRISPR/Cas9 介导的基因操作,用于创建具有无克隆方法的单氨基酸取代和 floxed 小鼠。
Sci Rep. 2017 Feb 8;7:42244. doi: 10.1038/srep42244.
7
The ClusPro web server for protein-protein docking.ClusPro 网页服务器,用于蛋白质-蛋白质对接。
Nat Protoc. 2017 Feb;12(2):255-278. doi: 10.1038/nprot.2016.169. Epub 2017 Jan 12.
8
Refining the molecular organization of the cardiac intercalated disc.精细化心脏闰盘的分子组织结构。
Cardiovasc Res. 2017 Mar 1;113(3):259-275. doi: 10.1093/cvr/cvw259.
9
MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy.MLP 和 CARP 与扩张型心肌病中的慢性 PKCα 信号传导有关。
Nat Commun. 2016 Jun 29;7:12120. doi: 10.1038/ncomms12120.
10
Arrhythmogenic Right Ventricular Cardiomyopathy - 4 Swedish families with an associated PKP2 c.2146-1G>C variant.致心律失常性右室心肌病——4个瑞典家庭伴有相关的PKP2基因c.2146-1G>C变异
Am J Cardiovasc Dis. 2016 May 18;6(2):55-65. eCollection 2016.

桥粒 COP9 调控致心律失常性右室心肌病/发育不良中的蛋白质组降解。

Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

机构信息

Department of Medicine, University of California San Diego, La Jolla, California, USA.

Institute of Medicine, Department of Molecular and Clinical Medicine and Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.

出版信息

J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI137689.

DOI:10.1172/JCI137689
PMID:33857019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159691/
Abstract

Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell-cell communication, as destabilization/breakdown of the desmosomal proteome is a hallmark of genetic-based desmosomal-targeted diseases, such as the cardiac disease arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). However, no information exists on whether there are resident proteins that regulate desmosomal proteome homeostasis. Here, we uncovered a cardiac constitutive photomorphogenesis 9 (COP9) desmosomal resident protein complex, composed of subunit 6 of the COP9 signalosome (CSN6), that enzymatically restricted neddylation and targeted desmosomal proteome degradation. CSN6 binding, localization, levels, and function were affected in hearts of classic mouse and human models of ARVD/C affected by desmosomal loss and mutations, respectively. Loss of desmosomal proteome degradation control due to junctional reduction/loss of CSN6 and human desmosomal mutations destabilizing junctional CSN6 were also sufficient to trigger ARVD/C in mice. We identified a desmosomal resident regulatory complex that restricted desmosomal proteome degradation and disease.

摘要

蛋白质降解途径失调被认为是人类疾病的重要介质。这一机制可能与桥粒蛋白密切相关,桥粒蛋白在组织架构和细胞间通讯中起着关键的结构作用,因为桥粒蛋白组的不稳定/破坏是基于遗传的桥粒靶向疾病的特征,如心律失常性右室发育不良/心肌病(ARVD/C)。然而,目前尚不清楚是否存在调节桥粒蛋白组稳态的固有蛋白。在这里,我们发现了一种心脏组成型光形态发生 9(COP9)桥粒固有蛋白复合物,由 COP9 信号体的亚基 6(CSN6)组成,该复合物具有酶限制的 neddylation 和靶向桥粒蛋白组降解的作用。在经典的 ARVD/C 小鼠和人类模型的心脏中,分别受桥粒缺失和突变影响,CSN6 的结合、定位、水平和功能均受到影响。由于 CSN6 的连接减少/丢失以及破坏连接 CSN6 的人类桥粒突变导致桥粒蛋白组降解失去控制,也足以在小鼠中引发 ARVD/C。我们鉴定了一种桥粒固有调节复合物,该复合物限制桥粒蛋白组的降解和疾病的发生。